Dr. Paul Marik counters the monied special interests of medical journals with evidence-based, conflict-of-interest-free research
“We had a really successful protocol for treating COVID in the hospital. We knew it was effective. My results were better than any of my colleagues’. But the hospital decided to basically outlaw what I was doing.”
As Chief Scientific Officer of the FLCCC Alliance, Dr. Marik has continued his prolific research output focused on patient care. Since 2020 he has published numerous prevention, treatment and recovery protocols on Spike Protein-Induced diseases. In 2023-24 he authored the monographs Cancer Care and Managing Depression, and collaborated with Dr. Yusuf (JP) Saleeby and Matthew T.J. Halma on Autophagy for Spike Protein Disease, published in the journal Endocrine and Metabolic Science.
Dr. Marik’s personal approach to the research process is clear:
“In order for research to be unbiased, scientifically valid and honest one has to remove all conflicts of interest. Even a small conflict of interest is a conflict of interest.”
In the U.S. conflict of interest and medical journals have been interlocked for nearly a century. Not all medical journals are “captured,” but most are conflicted. The Medical Industrial Complex has consistently resorted to a combination of academic payola and ham-handed intimidation tactics to discredit rogue researchers and clinicians. Medical journal editors beholden to monied “system” interests have ‘rug-pulled’ published peer-reviewed research they once solidly stood behind, and “hijacked” many conclusions or held papers hostage until the authors agreed to whatever changes were necessary to validate predetermined results.
Dr. Marik directly experienced this type of professional character smear connected with a Vitamin C Sepsis research paper in early 2020– before COVID. He understands the current system is broken, ripe for a healthcare revolution, which drives a sense of urgency in his current research.
One significant new project is the FLCCC Observational Cancer Study. The collaboration with Dr. Kathleen Ruddy and five U.S. clinics “will track patient responses to various adjunct cancer therapies using repurposed drugs. The aim is to determine changes in the five-year survival rate of several types of cancer including breast, prostate, lung, and colorectal.”
”This is a groundbreaking study that will hopefully serve as a model for future research,” he said.
At the FLCCC, we’re harnessing the momentum of each of you—the brave truth-tellers—to launch a healthcare revolution. Join us today and stake your claim in our crusade for Honest Medicine.™ Make a gift to help fund our critical work.
Now through March 26, 2024, each and every gift made to the FLCCC Alliance will be matched dollar for dollar up to $100,000 thanks to two kind benefactors.
Dr. Marik announces the cancer study partnership with Dr. Ruddy at the Winter 2024 FLCCC Educational Conference.
Working with research teams and collaborating with other physicians and scientists, Dr. Paul Marik has developed protocols for Sepsis, COVID, and RSV as well as treatments for the chronic conditions of metabolic syndrome and diabetes. He has been cited more than 54,000 times in peer-reviewed publications and has published more than 500 peer-reviewed articles in medical journals. Dr. Marik co-founded The FLCCC Alliance four years ago in a drive to develop a life-saving treatment for SARS COV II.
As Director of the ICU at Norfolk General Hospital, Dr. Marik drew on years of critical care clinical experience to create a treatment protocol.